alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### Gregory FOSTER; Reginald Cline, Appellants, v. GENERAL MOTORS CORPORATION, Appellee.

No. 93-3279EA.

United States Court of Appeals, Eighth Circuit.

Submitted March 18, 1994.

Decided March 23, 1994.

Sheila F. Campbell, Little Rock, AR, for appellants.

Robert L. Henry, III and Shayne D. Smith, Little Rock, AR, for appellee.

Before FAGG, Circuit Judge, BRIGHT, Senior Circuit Judge, and WOLLMAN, Circuit Judge.

PER CURIAM.

Gregory Foster and Reginald Cline brought this product liability action against General Motors Corporation (GMC), claiming they were injured in an accident caused by a design defect in the gearshift of Foster’s *839Chevrolet automobile. Foster and Cline appeal the jury’s verdict for GMC, contending the district court erroneously admitted two versions of the police accident report. We disagree and affirm.

At trial, GMC offered the original police report prepared by the investigating officer. The officer was experienced in motor vehicle accident investigations, he conducted a neutral investigation shortly after the accident occurred, and he prepared his report the next day. This report was clearly admissible under the hearsay exception for public records. Fed.R.Evid. 803(8); *Simmons v. Chicago & N.W. Transp. Co.,*993 F.2d 1326, 1327-28 (8th Cir.1993).

GMC also offered a copy of the police report (the second report) that its investigator received from Foster and Cline’s attorney. The second report was a copy of the original report with alterations in a different handwriting blaming the accident on the au: tomobile’s gearshift. Foster testified the investigating officer gave him the second report and he delivered the report to his attorney. Contrary to Foster and Cline’s argument that the second report lacked the trustworthiness needed for admission under the public records hearsay exception, the second report was not hearsay because GMC did not offer the report to prove its truth. *See*Fed. R.Evid. 801(c). Instead, GMC offered the second report, and the investigating officer’s testimony denying that he made the alterations, to impeach Foster’s direct testimony that he did not alter the report before giving it to his attorney.

Foster and Cline also argue the second report was extrinsic evidence barred for impeachment purposes by Federal Rule of Evidence 608(b). We disagree. Rule 608(b) does not apply to extrinsic evidence that is offered to impeach a witness’s testimony on a material issue. *See Boutros v. Canton Regional Transit Auth.,*997 F.2d 198, 205 (6th Cir.1993). Thus, the district court properly admitted the second report because the report was relevant to GMC’s defense that Foster and Cline manufactured their claim that a defective gearshift caused the accident.

Finally, we reject Foster and Cline’s argument that the second report should have been excluded under Federal Rule of Evidence 403. Admission of the second report did not unfairly prejudice Foster and Cline after Foster testified he did not alter the report.

Accordingly, we affirm.
[Federal Register Volume 89, Number 12 (Thursday, January 18, 2024)]
[Notices]
[Pages 3406-3407]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-00826]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to 5 U.S.C. 1009(d), notice is hereby given of the 
following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of the Director, Office of 
Strategic Business Initiatives, Office of the Chief Operating Officer, 
CDC, pursuant to Public Law 92-463. The grant applications and the

[[Page 3407]]

discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.
    Name of Committee: Disease, Disability, and Injury Prevention and 
Control Special Emphasis Panel (SEP)--RFA-IP-24-045, Network of 
Community Cohorts for Monitoring Changes in Respiratory Virus 
Epidemiology (Pandemic Preparedness Cohorts).
    Dates: April 25-26, 2024.
    Times: 10 a.m.-5 p.m., EDT.
    Place: Videoconference.
    Agenda: To review and evaluate grant applications.
    For Further Information Contact: Gregory Anderson, MS, M.P.H, 
Scientific Review Officer, National Center for HIV, Viral Hepatitis, 
STD, and TB Prevention, Centers for Disease Control and Prevention, 
1600 Clifton Road NE, Mailstop H24-6, Atlanta, Georgia 30329-4027. 
Telephone: (404) 718-8833; Email: <a href="/cdn-cgi/l/email-protection#b8fff9d6dcddcacbd7d6f8dbdcdb96dfd7ce"><span class="__cf_email__" data-cfemail="c98e88a7adacbbbaa6a789aaadaae7aea6bf">[email protected]</span></a>.
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-00826 Filed 1-17-24; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
**Exhibit 32**

AMANASU ENVIRONMENT CORPORATION**Certification of Chairman and Chief Executive Officer			Pursuant to 18 U.S.C. Section 1350,			As Adopted Pursuant to			Section 906 of the Sarbanes-Oxley Act of 2002**

		  Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of          the registrant certifies, to the best of his knowledge, that the registrant's          Quarterly Report on Form 10-QSB for the period ended March 31, 2008 (the "Form          10-QSB") fully complies with the requirements of Section 13(a) or 15(d) of          the Securities Exchange Act of 1934 and that the information contained in the Form          10-QSB, fairly presents, in all material respects, the financial condition          and results of operations of the registrant.		

 Dated: May 19, 2008
			 By: /s/ Atsushi Maki					Atsushi Maki					Chairman and Chief Executive Officer
**Exhibit 32**

AMANASU ENVIRONMENT CORPORATION**Certification of Chairman and Chief Executive Officer			Pursuant to 18 U.S.C. Section 1350,			As Adopted Pursuant to			Section 906 of the Sarbanes-Oxley Act of 2002**

		  Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of          the registrant certifies, to the best of his knowledge, that the registrant's          Quarterly Report on Form 10Q for the period ended September 30, 2009 (the "Form          10Q") fully complies with the requirements of Section 13(a) or 15(d) of          the Securities Exchange Act of 1934 and that the information contained in the Form          10Q, fairly presents, in all material respects, the financial condition          and results of operations of the registrant.		

 Dated: November 23, 2009
			 By: /s/ Atsushi Maki					Atsushi Maki					Chairman & Chief Executive Officer			 By: /s/ Lina Lei					Lina Lei					Chief Financial Officer
Exhibit
      32.2




**CERTIFICATION
      PURSUANT TO**




**18
      U.S.C. SECTION 1350,**




**AS
      ADOPTED PURSUANT TO**




SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002




In
      connection with the Quarterly Report of In Veritas Medical Diagnostics, Inc.
      (the "Company") on Form 10-QSB for the quarter ended January 31, 2007 as filed
      with the Securities and Exchange Commission on the date hereof (the "Report"),
      I, Martin E. Thorp, Chief Financial Officer of the Company, certify, pursuant
      to
      18 U.S.C. section 906 of the Sarbanes-Oxley Act of 2002, that:




(1)
      The
      Report fully complies with the requirements of section 13(a) or 15(d) of the
      Securities and Exchange Act of 1934; and




(2)
      The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and result of operations of the Company.




A
      signed
      original of this written statement required by Section 906 has been provided
      to
      In Veritas Medical Diagnostics, Inc. and will be retained by In Veritas Medical
      Diagnostics, Inc. and furnished to the Securities and Exchange Commission or
      its
      staff upon request.


April
              25, 2007
            
            /s/ Martin
              E.
              ThorpMartin
              E. ThorpChief
                Financial Officer
#### Radey H. MOHAMMAD, Plaintiff-Appellant, v. Ronald ANGELONE; James Jenkins, Defendants-Appellees.

No. 02-6948.

United States Court of Appeals, Fourth Circuit.

Submitted Dec. 10, 2002.

Decided Feb. 10, 2003.

Matthew P. Geary, Richmond, Virginia, for Appellant. Jerry W. Kilgore, Attorney General, Richard C. Vorhis, Assistant Attorney General, Richmond, Virginia, for Appellees.

Before NIEMEYER, LUTTIG, and WILLIAMS, Circuit Judges.

Affirmed by unpublished PER CURIAM opinion.

PER CURIAM.

Radey H. Mohammad appeals the district court’s order granting summary judgment for the defendants in his 42 U.S.C. § 1983 (2000) complaint. We have reviewed the record and find no reversible error. Accordingly, we affirm for the reasons stated by the district court. *See Mohammad v. Angelone,*No. CA-01-819-3 (E.D.Va. May 22, 2002). We dispense with oral argument because the facts and legal contentions are adequately presented in *670the materials before the court and argument would not aid the decisional process.

*AFFIRMED.*
<PAGE>

                                                                    Exhibit 32.2

     Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

I, James M. Mitchell, Chief Financial Officer of Family Home Health Services
Inc. (the "registrant"), have executed this certification for furnishing to the
Securities and Exchange Commission in connection with the filing with the
Commission of the registrant's Quarterly Report on Form 10-Q for the period
ended June 30, 2006 (the "Report"). I hereby certify that, to my knowledge:

     (1) the Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

     (2) the information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
registrant as of and for the end of that period.


August 21, 2006                         /s/ James M. Mitchell
                                        ----------------------------------------
                                        James M. Mitchell
                                        Chief Financial Officer
### IN THE CO URT OF APPEALS OF TE NNE SS EE
AT KNOX VILLE

Mar ch 8, 2 01 1 S es si on

AMERICAN GE NERAL FINANCI AL SERVI CES, I NC. v. MARTIN
GOS S/ UNKNOW N TENANT OF FORECLO SED PROPERTY

A p p e a l f r o m t h e C i r c u i t C o u r t f o r K n o x C o u n t y
N o

. 1 2 1
, 8 1 0 D a l e C

. W o r k m a n , J u d g e

N o

. E 2 0 1 0

- 0 1 7 1 0

- C O A

- R 3

- C V

- F i l e d A p r i l 7
, 2 0 1 1

C H A R LE S D

. S U S A N O

, J R

. , J u d g e , c o n c u r r i n g i n p a r t a n d d i s s e n t i n g i n p a r t

.

I c o n c u r i n t h e d e c i s i o n o f t h e m a j o r i t y t o a f

f i r m t h e t r i a l c o u r t ’ s j u d g m e n t i n f a v o r

o f A m e r i c a n G e n e r a l F i n a n c i a l S e r v i c e s , I n c

. I r e s p e c t f u l l y d i s s e n t f

r o m t h e m a

j o r i t y ’ s

c o n c l u s i o n t h a t M r

. G o s s ’ s a p p e a l i s n o t s o d e v o i d o f m e r i t a s t o w a r r a n t a h o l d i n g t h a t h i s

a p p e a l i s f

r i v o l o u s i n n a t u r e

. W h e n a n a p p e l l a n t s e e k s t o r e v e r s e o r m o d i f y a t r i a l c o u r t ’ s j u d g m e n t b a s e d u p o n a n a l l e g e d e r r o r g r o u n d e d i n t h e f a c t s o f t h e c a s e , b u t f

a i l s t o p r e s e n t

u s w i t h a v e r b a t i m t r a n s c r i p t o r s t a t e m e n t o f t h e e v i d e n c e , t h e a p p e l l a n t ’ s a p p e a l h a s n o

c h a n c e o f s u c c e s s

. A n a p p e a l i s d e e m e d f r i v o l o u s i f i t i s d e v o i d o f m e r i t o r i f i t h a s n o

r e a s o n a b l e c h a n c e o f s u c c e s s

. B u r s a c k v

. W i l s o n , 9 8 2 S

. W

. 2 d 3 4 1

, 3 4 5 ( T e n n

. C t

. A p p

. 1 9 9 8 ) ; I n d u s t r i a l D e v

. B d

. v

. H a n c o c k

, 9 0 1 S

. W

. 2 d 3 8 2

, 3 8 5 ( T e n n

. C t

. A p p

. 1 9 9 5 )

. S e e

a l s o L i n n v

. H o w a r d

, E 2 0 0 6

- 0 0 0 2 4

- C O A

- R 3

- C V

, 2 0 0 7 W L 2 0 8 4 4 2 a t * 5 ( T e n n

. C t

. A p p

. E

. S

. , f i l e d o n J a n u a r y 2 6

, 2 0 0 7 )

. W h e n t h e o n l y i s s u e s o n a n a p p e a l a r e f a c t u a l o n e s

– a s

o p p o s e d t o l e g a l q u e s t i o n s

– w e m u s t h a v e a r e c o r d t h a t p e r m i t s u s t o r e a c h t h o s e i s s u e s

. I n

m y j u d g m e n t

, t h i s a p p e a l i s

– b y d e f i n i t i o n

– a f

r i v o l o u s a p p e a l

. I w o u l d r e m a n d f o r a h e a r i n g t o d e t e r m i n e “

j u s t d a m a g e s ” d u e t h e a p p e l l e e p u r s u a n t t o T e n n

. C o d e A n n

. § 2 7

- 1

- 1 2 2 ( 2 0 0 0 )

.

A c c o r d i n g l y , I c o n c u r i n p a r t a n d r e s p e c t f u l l y d i s s e n t i n p a r t

.

_ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ C H A R L E S D

. S U S A N O

, J R

. , J U D G E
EXHIBIT 10.31

	 






June 14, 2011



Mr. John A. King

213 N. Bridge Creek Drive

Jacksonville, Florida  32259

 

Re:      SafedoX, Inc.



Finder's Fee Letter Agreement



Dear John:



This letter will serve to memorialize our agreement with respect to payment of finder's fees for your
services in introducing us to investors who potentially would be interested in considering an
investment in our company, pursuant to our current private offering.



We are seeking capital with which to establish our SafedoXTM products in their markets and are
seeking to locate potential investors. You have agreed to use your best efforts to introduce our
company to investors who potentially would be interested in making an investment in our company.



In consideration of your efforts under this agreement, we have agreed to pay to you shares of our
common stock at the rate of one share for every $3.00 invested by each investor introduced to us by
you.



In performing your duties as a finder, you are to do no more than refer potential investors to us and
to make introductions of them.  You agree not to perform any services that would normally be
performed by a licensed securities broker or dealer, as you will not be acting in such capacity.  When
you have made an introduction, you will have performed all of the service required for you to have
earned the described finder's fee, should such referred potential investor invest funds in our
company.  You will be paid your cash compensation at such time as we have received available
funds from an investor introduced to us by you.



With respect to introductions to be made by you, you are to advise us in writing, including by e-mail
to manoj@safedox.com, of the identity of such potential investor.  If such referred investor is already
known to us and is an investor with whom we have an existing relationship through our own efforts,
we will advise you within three (3) days of the date we receive your notice of reference, and you will
not be considered a finder as to that potential investor.  If we do not so advise you within such three-day period, you will be considered a finder as to that potential investor.



If this letter properly reflects your understanding, please indicate such in the space below. 



We thank you for your assistance and look forward to working with you. 



Sincerely,



SAFEDOX, INC.



By: /s/ MANOJ PATEL

            Manoj Patel

            President



ACCEPTED AND AGREED:



/s/ JOHN A. KING

John A. King



Date: June 14, 2011
----

----

I Actos adoptados en aplicación de los Tratados CE/Euratom cuya publicación es obligatoria

REGLAMENTOS

----

REGLAMENTO (CE) No 5/2007 DE LA COMISIÓN

de 5 de enero de 2007

por el que se establecen valores globales de importación para la determinación del precio de entrada de determinadas frutas y hortalizas

LA COMISIÓN DE LAS COMUNIDADES EUROPEAS,

Visto el Tratado constitutivo de la Comunidad Europea,

Visto el Reglamento (CE) no 3223/94 de la Comisión, de 21 de diciembre de 1994, por el que se establecen disposiciones de aplicación del régimen de importación de frutas y hortalizas (1), y, en particular, el apartado 1 de su artículo 4,

Considerando lo siguiente:

HA ADOPTADO EL PRESENTE REGLAMENTO:

Artículo 1

Los valores globales de importación a que se refiere el artículo 4 del Reglamento (CE) no 3223/94 quedan fijados según se indica en el cuadro del anexo.

Artículo 2

El presente Reglamento entrará en vigor el 6 de enero de 2007.

El presente Reglamento será obligatorio en todos sus elementos y directamente aplicable en cada Estado miembro.

Hecho en Bruselas, el 5 de enero de 2007.

Por la Comisión

Jean-Luc DEMARTY

Director General de Agricultura y Desarrollo Rural

----

(1)DO L 337 de 24.12.1994, p. 66. Reglamento modificado en último lugar por el Reglamento (CE) no 386/2005 (DO L 62 de 9.3.2005, p. 3).

----

ANEXO

del Reglamento de la Comisión, de 5 de enero de 2007, por el que se establecen los valores globales de importación para la determinación del precio de entrada de determinadas frutas y hortalizas

----

(1)  Nomenclatura de países fijada por el Reglamento (CE) no 1833/2006 de la Comisión (DO L 354 de 14.12.2006, p. 19). El código «ZZ» significa «otros orígenes».

----
```

[Congressional Bills 104th Congress]
[From the U.S. Government Publishing Office]
[S. 1516 Introduced in Senate (IS)]

104th CONGRESS
  2d Session
                                S. 1516

 Making appropriations to the Department of Health and Human Services 
 for retirement pay and medical benefits for commissioned officers of 
  the Public Health Service for the fiscal year ending September 30, 
                                 1996.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

              January 5 (legislative day, January 3), 1996

   Mr. Robb introduced the following bill; which was read twice and 
              referred to the Committee on Appropriations

_______________________________________________________________________

                                 A BILL

 
 Making appropriations to the Department of Health and Human Services 
 for retirement pay and medical benefits for commissioned officers of 
  the Public Health Service for the fiscal year ending September 30, 
                                 1996.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled, That there is hereby 
appropriated, out of any money in the Treasury not otherwise 
appropriated, for the Department of Health and Human Services for the 
fiscal year ending September 30, 1996, for retirement pay and medical 
benefits of Public Health Service Commissioned Officers as authorized 
by law, and for payments under the Retired Serviceman's Family 
Protection Plan and Survivor Benefits Plan and for medical care of 
dependents and retired personnel under chapter 55 of title 10, United 
States Code, and for payments pursuant to section 229(b) of the Social 
Security Act (42 U.S.C. 429(b)), such amounts as may be required during 
such fiscal year.
                                 <all>
```
EXHIBIT 23.1

               CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS

As independent certified public accountants, we hereby consent to the
incorporation of our report included in this Form 10-K, into the Company's
previously filed Registration Statements on Form S-8 (File No. 333-07021), Form
S-3 (File No. 333-40429) and File No. 333-55881, Post-Effective Amendment No. 1
on Form S-8 to Form S-4 (333-51479-01), and Post-Effective Amendment No. 3 on
Form S-3 to Form S-4 (333-51479-03).

ARTHUR ANDERSEN LLP

Miami, Florida,
   March 30, 1999.
**EXHIBIT 32.1****CERTIFICATION**     Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of1934, as amended (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the UnitedStates Code (18 U.S.C. § 1350), Hollings C. Renton, Chairman of the Board, President and ChiefExecutive Officer of Onyx Pharmaceuticals, Inc. (the “Company”), and Gregory W. Schafer, VicePresident and Chief Financial Officer of the Company, each hereby certify that, to the best of hisknowledge:**1.** The Company’s Annual Report on Form 10-K for the period ended December 31, 2006, to whichthis Certification is attached as Exhibit 32.1 (the “Annual Report”), fully complies with therequirements of Section 13(a) or Section 15(d) of the Exchange Act; and **2.** The information contained in the Annual Report fairly presents, in all material respects, thefinancial condition and results of operations of the Company.Dated: March 5, 2007         /s/ Hollings C. Renton   Hollings C. Renton   Chairman of the Board, President
EXHIBIT 32.2

CERTIFICATION OF VICE PRESIDENT, FINANCE  CALLISTO PHARMACEUTICALS, INC.  FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2007  PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED  PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002

I am the Vice President, Finance of Callisto Pharmaceuticals, Inc., a Delaware corporation (the "Company"). I am delivering this certificate in connection
with the Form 10-Q of the Company for the quarter ended September 30, 2007 and filed with the Securities and Exchange Commission ("Form 10-Q").

Pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I hereby certify that, to the best of my knowledge, the
Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 and that the information contained in the
Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

|Date: November 14, 2007 | /s/BERNARD F. DENOYERBernard F. Denoyer Vice President, Finance
|----------------------- | ---------------------------------------------------------------

---



QuickLinks
Bureau of Labor Statistics

Series Id:

Series title:

Labor force status:

Type of data:

Age:

Years:

Year Qtr1 Qtr2 Qtr3 Qtr4 Annual

2011 1513

Unemployed

Number in thousands

30 to 34 years

2011 to 2011

Labor Force Statistics from the Current Population Survey

Original Data Value

LNU03024933Q

Not Seasonally Adjusted

(Unadj) Unemployment Level - 30-34 yrs.

Source: Bureau of Labor Statistics Generated on: May 16, 2011 (02:08:48 PM)